Chemours vs Methanex
Chemours is the larger business, with $5.81bn of revenue in fiscal 2025 against $3.59bn for Methanex (1.6 times as much). Chemours grew faster (0.4% against -3.5%). Methanex kept more of each dollar of sales as profit: a net margin of 4.0% against -6.6%.
| Latest fiscal year | ChemoursCC, 2025 | MethanexMEOH, 2025 |
|---|---|---|
| Revenue | $5.81bn | $3.59bn |
| Revenue growth | 0.4% | -3.5% |
| Net income | −$386m | $145m |
| Operating margin | — | 12.0% |
| Net margin | -6.6% | 4.0% |
| Return on equity | -94.0% | 6.4% |
| Free cash flow | $51.0m | $917m |
| Cash | $670m | $425m |
| Total debt | $4.18bn | $2.75bn |
| Debt to equity | — | 112.7% |
| Dividend per share | $0.51 | — |
| Dividend yield | 2.7% | 1.1% |
| Share buybacks | — | — |
| Employees | 5,700 | — |
| Market value | $1.98bn | $4.97bn |
| Price vs our value range | — | Within our value range |
| Moat score | 46 (Moderate) | — |
| Insider trades, 12 months | 7 buys, 0 sales | 0 buys, 0 sales |